Oct 16 (Reuters) - ContraFect Corp :
* CONTRAFECT ANNOUNCES FDA CLEARANCE OF CF-370 IND APPLICATION TO PROCEED WITH PHASE 1 CLINICAL STUDY
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com))
Oct 16 (Reuters) - ContraFect Corp :
* CONTRAFECT ANNOUNCES FDA CLEARANCE OF CF-370 IND APPLICATION TO PROCEED WITH PHASE 1 CLINICAL STUDY
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com))
Comments